A nurse prepares a 4th dosage of coronavirus illness (COVID-19) vaccine as part of a trial in Israel, at Sheba Medical Center in Ramat Gan, Israel December 27,2021 REUTERS/Ronen Zvulun
Register now totally free endless access to Reuters.com
JERUSALEM, Jan 23 (Reuters) – A 4th dosage of COVID-19 vaccine provided to individuals over 60 in Israel made them 3 times more resistant to major disease than thrice-vaccinated individuals in the very same age, Israel’s Health Ministry stated on Sunday.
The ministry likewise stated the 4th dosage, or 2nd booster, made individuals over 60 two times as resistant to infection than those in the age who got 3 shots of the vaccine.
A initial research study released by Israel’s Sheba medical centre last Monday discovered that the 4th shot increases antibodies to even greater levels than the 3rd however “most likely” not to the point that it might totally ward off the extremely transmissible Omicron version.
Register now free of charge endless access to Reuters.com
Israel started providing a 4th dosage of the Pfizer/BioNtech vaccine to individuals over 60 previously this month as Omicron swept the nation.
The ministry stated on Sunday the research study it carried out with numerous significant Israeli universities and the Sheba centre compared 400,000 individuals over 60 who got the 2nd booster with 600,000 individuals in the age who were offered a 3rd shot more than 4 months earlier.
As in other places, Israel has actually seen COVID-19 cases spiral due to Omicron. It has actually logged no deaths from the variation.
Register now free of charge unrestricted access to Reuters.com
Reporting by Jeffrey Heller;
Modifying by Andrew Cawthorne and Frances Kerry
Our Standards: The Thomson Reuters Trust Principles.
Comments
Post a Comment